The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis

Developmental Biology

Volumn 333, Issue 1, 2009, Pages 173-185

  Meyer, Sara E ^a   Zinser, Glendon M ^a   Stuart, William D ^a   Pathrose, Peterson ^a   Waltz, Susan E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Hepatocyte growth factor like protein; Mammary development; Mammary gland; Met receptor; Receptor tyrosine kinase; Ron receptor

Indexed keywords

ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROTEIN TYROSINE KINASE; RON RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PUBERTY; REGULATORY MECHANISM;

MUS;

EID: 68349154504     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.06.028     Document Type: Article

References (49)

1. Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. J. Mammary Gland Biol. Neoplasia 7 (2002) 39-48
2. Camp E.R., Liu W., Fan F., Yang A., Somcio R., and Ellis L.M. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann. Surg. Oncol. 12 (2005) 273-281
3. Cardiff R.D., and Kenney N. Mouse mammary tumor biology: a short history. Adv. Cancer Res. 98 (2007) 53-116
4. Chodosh L.A., Gardner H.P., Rajan J.V., Stairs D.B., Marquis S.T., and Leder P.A. Protein kinase expression during murine mammary development. Dev. Biol. 219 (2000) 259-276
5. Comoglio P.M., and Boccaccio C. The HGF receptor family: unconventional signal transducers for invasive cell growth. Genes Cells 1 (1996) 347-354
6. Danilkovitch A., and Leonard E.J. Kinases involved in MSP/RON signaling. J. Leukoc. Biol. 65 (1999) 345-348
7. Danilkovitch-Miagkova A. Oncogenic signaling pathways activated by RON receptor tyrosine kinase. Curr. Cancer Drug Targets 3 (2003) 31-40
8. Danilkovitch-Miagkova A., and Leonard E.J. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors. Histol. Histopathol. 16 (2001) 623-631
9. Davies J.A. Do different branching epithelia use a conserved developmental mechanism?. BioEssays 24 (2002) 937-948
10. Dickson C., Creer A., and Fantl V. Mammary gland oncogenes as indicators of pathways important in mammary gland development. Oncogene 19 (2000) 1097-1101
11. Fata J.E., Mori H., Ewald A.J., Zhang H., Yao E., Werb Z., and Bissell M.J. The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev. Biol. 306 (2007) 193-207
12. Feng Y., Manka D., Wagner K.U., and Khan S.A. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14718-14723
13. Gaudino G., Follenzi A., Naldini L., Collesi C., Santoro M., Gallo K.A., Godowski P.J., and Comoglio P.M. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13 (1994) 3524-3532
14. Hendrickson W.A. Transduction of biochemical signals across cell membranes. Q. Rev. Biophys. 38 (2005) 321-330
15. Hennighausen L., and Robinson G.W. Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 6 (2005) 715-725
16. Hinck L., and Silberstein G.B. Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res. 7 (2005) 245-251
17. Howlin J., McBryan J., and Martin F. Pubertal mammary gland development: insights from mouse models. J. Mammary Gland Biol. Neoplasia 11 (2006) 283-297
18. Humphreys R.C., Lydon J., O'Malley B.W., and Rosen J.M. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol. 11 (1997) 801-811
19. Joseph H., Gorska A.E., Sohn P., Moses H.L., and Serra R. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 10 (1999) 1221-1234
20. Korach K.S., Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Kimbro K.S., Eddy E.M., Migliaccio S., Snedeker S.M., Lubahn D.B., Schomberg D.W., and Smith E.P. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51 (1996) 159-186 discussion 186-8
21. Kouros-Mehr H., and Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev. Dyn. 235 (2006) 3404-3412
22. Kumar R., and Wang R.A. Protein kinases in mammary gland development and cancer. Microsc. Res. Tech. 59 (2002) 49-57
23. Lanigan F., O'Connor D., Martin F., and Gallagher W.M. Molecular links between mammary gland development and breast cancer. Cell. Mol. Life Sci. 64 (2007) 3159-3184
24. Leonis M.A., Thobe M.N., and Waltz S.E. Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Future Oncol. 3 (2007) 441-448
25. Longati P., Comoglio P.M., and Bardelli A. Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. Curr. Drug Targets 2 (2001) 41-55
26. Lu P., Sternlicht M.D., and Werb Z. Comparative mechanisms of branching morphogenesis in diverse systems. J. Mammary Gland Biol. Neoplasia 11 (2006) 213-228
27. Maggiora P., Marchio S., Stella M.C., Giai M., Belfiore A., De Bortoli M., Di Renzo M.F., Costantino A., Sismondi P., and Comoglio P.M. Overexpression of the RON gene in human breast carcinoma. Oncogene 16 (1998) 2927-2933
28. Nam J.S., Terabe M., Kang M.J., Chae H., Voong N., Yang Y.A., Laurence A., Michalowska A., Mamura M., Lonning S., Berzofsky J.A., and Wakefield L.M. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res. 68 (2008) 3915-3923
29. Niemann C., Brinkmann V., Spitzer E., Hartmann G., Sachs M., Naundorf H., and Birchmeier W. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell. Biol. 143 (1998) 533-545
30. Nogawa H., Morita K., and Cardoso W.V. Bud formation precedes the appearance of differential cell proliferation during branching morphogenesis of mouse lung epithelium in vitro. Dev. Dyn. 213 (1998) 228-235
31. Peace B.E., Toney-Earley K., Collins M.H., and Waltz S.E. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Res. 65 (2005) 1285-1293
32. Pollard J.W. Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 3 (2001) 230-237
33. Robles A.I., and Varticovski L. Harnessing genetically engineered mouse models for preclinical testing. Chem. Biol. Interact. 171 (2008) 159-164
34. Silberstein G.B. Postnatal mammary gland morphogenesis. Microsc. Res. Tech. 52 (2001) 155-162
35. Soriano J.V., Pepper M.S., Nakamura T., Orci L., and Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell. Sci. 108 Pt 2 (1995) 413-430
36. Spooner B.S., Bassett K.E., and Spooner Jr. B.S. Embryonic salivary gland epithelial branching activity is experimentally independent of epithelial expansion activity. Dev. Biol. 133 (1989) 569-575
37. Sternlicht M.D. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 8 (2006) 201
38. Sternlicht M.D., Kouros-Mehr H., Lu P., and Werb Z. Hormonal and local control of mammary branching morphogenesis. Differentiation 74 (2006) 365-381
39. Sutherland B.W., Knoblaugh S.E., Kaplan-Lefko P.J., Wang F., Holzenberger M., and Greenberg N.M. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res. 68 (2008) 3495-3504
40. Wagh P.K., Peace B.E., and Waltz S.E. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv. Cancer Res. 100 (2008) 1-33
41. Waltz S.E., Eaton L., Toney-Earley K., Hess K.A., Peace B.E., Ihlendorf J.R., Wang M.H., Kaestner K.H., and Degen S.J. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Invest. 108 (2001) 567-576
42. Wang M.H., Iwama A., Skeel A., Suda T., and Leonard E.J. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3933-3937
43. Wang M.H., Montero-Julian F.A., Dauny I., and Leonard E.J. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 13 (1996) 2167-2175
44. Watson C.J., and Khaled W.T. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 135 (2008) 995-1003
45. Wiesen J.F., Young P., Werb Z., and Cunha G.R. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126 (1999) 335-344
46. Xie W., Paterson A.J., Chin E., Nabell L.M., and Kudlow J.E. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol. 11 (1997) 1766-1781
47. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K.M., Birchmeier C., and Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131 (1995) 215-226
48. Yant J., Buluwela L., Niranjan B., Gusterson B., and Kamalati T. In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp. Cell Res. 241 (1998) 476-481
49. Zinser G.M., Leonis M.A., Toney K., Pathrose P., Thobe M., Kader S.A., Peace B.E., Beauman S.R., Collins M.H., and Waltz S.E. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Res. 66 (2006) 11967-11974